Celprogen's cancer stem cells are available for basic science research and drug discovery. The cancer stem cells are as follows: Brain, Breast, Colon, Kidney, Leukemia, Liver, Lungs, Melanoma, Ovarian, and Pancreatic & Prostate.
Celprogen provides the Cancer Stem Cell Tissue culture system which includes cells, pre-coated flasks with extracellular matrix and Medium for growth and proliferation of these cells.
About Celprogen Inc.
Celprogen Inc. is a global Stem Cell Research & Therapeutics company which is developing a proprietary portfolio of unique cancer therapeutics products and life science research tools that includes stem cell technologies for regenerative medicine, as well as bio-engineering products for tissue & organ transplants. Headquartered in San Pedro, California, Celprogen is committed to the research, development, and manufacture of quality Stem Cell products to serve our global community.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:
Abiomed, . "Celprogen Launches Cancer Stem Cells." Medical News Today. MediLexicon, Intl., 25 Jan. 2008. Web.
29 Mar. 2017. <http://www.medicalnewstoday.com/releases/95152.php>
Abiomed, . (2008, January 25). "Celprogen Launches Cancer Stem Cells." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.